FDA Raises New Problems for Invokana and Invokamet
This is Michael Brady Lynch, lead trial attorney for The Michael Brady Lynch Firm. The FDA issued today a new safety communication regarding the already controversial drugs Invokana and Invokamet (canagliflozin) highlighting safety concerns over bone breaks and reduced bone density. The safety communication can be read below: Drug Safety Communication – New Information on
Read MoreJPML Approves MDL of Bard IVC Cases
This is Michael Brady Lynch, lead trial attorney for The Michael Brady Lynch Firm. The case against the safety and effectiveness of the IVC filter just moved up a notch. The Judicial Panel on Multidistrict Litigation announced that all pending IVC Filter cases against C.R. Bard, Inc. and Bard Peripheral Vascular will be consolidated and
Read MoreADHD Medication Daytrana Linked to Permanent Skin Discoloration
This Michael Brady Lynch, lead trial attorney for The Michael Brady Lynch Firm. Another ADHD medication is coming under scrutiny for severe and permanent sides effects. On June 24, 2015, the Food and Drug Administration warned that Daytrana, a pharmaceutical patch approved to treat attention deficit hyperactivity disorder (ADHD), can cause permanent skin discoloration. The
Read MoreAttorney Michael Brady Lynch to Lecture at AAJ Convention in Montreal
This is Michael Brady Lynch, lead trial attorney for The Michael Brady Lynch Firm. It is new pleasure to announced that I have been selected to serve on the faculty of the upcoming AAJ Annual Convention educational seminar in Montreal entitled “Everything You Need to Know About Mass Torts (But Were Afraid to Ask)”, on Friday, July
Read MoreInvokana Linked to Ketoacidosis, Heart Attack and Renal Failure
This is Michael Brady Lynch, lead trial attorney for The Michael Brady Lynch Firm. The popular diabetes drug Invokana (Invokamet) has raised grave concerns over safety due to links between the use of the medication and kidney damage, myocardial infarction (heart attacks), other cardiovascular issues and ketoacidosis. National Invokana (Invokamet) lawsuits allege that the manufacturers
Read MoreMichael Brady Lynch to Lecture at Barry University School of Law
This is Michael Brady Lynch, lead trial attorney at The Michael Brady Lynch Firm. It is my pleasure to announce that I have been invited as a guest lecturer at Barry University School of Law’s Clinical Placement Program. Barry University School of Law’s Clinical Placement Program, in conjunction with the Florida Supreme Court, permits primarily third-year
Read MoreAttorney Amy E. German Joins The Michael Brady Lynch Firm
This is Michael Brady Lynch, lead trial attorney for The Michael Brady Lynch Firm. It is my true pleasure to announce that The Michael Brady Lynch Firm has added Amy E. German, Esq., as an associate in our pharmaceutical and medical device practice group. A little background on Amy: Attorney Amy E. German is an
Read More$2.5m DePuy ASR Hip Verdict in Favor of Plaintiff in Tulsa Trial
This is Michael Brady Lynch, lead trial attorney for The Michael Brady Lynch Firm. A recent verdict in favor of the plaintiff reminded Johnson & Johnson that their worries (and financial exposure) over defective ASR hips revised post-settlement are not over. A jury in Tulsa County, Oklahoma on February 3rd returned a $2.5 million compensatory
Read MoreFDA Revises Cancer Warning and Use Indications for Morcellators
This is Michael Brady Lynch, lead trial attorney for The Michael Brady Lynch Firm. The FDA has now weighed in on the use of morcellators for the removal of fibroid in women. Simply put, the warning are frightening. The “vast majority” of women getting fibroids removed should not be treated using devices called morcellators, which
Read MoreLevaquin Linked to Irreversible Peripheral Neuropathy
This is Michael Brady Lynch, lead trial attorney for The Michael Brady Lynch Firm. There are new concerns over the popular drug Levaquin (levofloxacin), which is is an antibiotic medication linked to severe and sometimes permanent nerve damage. Levaquin (levofloxacin) is an antibiotic medication that has been linked to a condition known as peripheral neuropathy (nerve
Read More